NCT07759206

Brief Summary

This study will evaluate whether gentle skin abrasion improves electromyographic signal quality during neuromuscular blockade monitoring in adult surgical patients. Participants will receive standard TwitchView electromyographic neuromuscular blockade monitoring on one wrist and TwitchView monitoring after gentle skin abrasion on the opposite wrist. The study will compare electromyographic response amplitudes and supramaximal stimulus currents between routine electrode application and electrode application after skin preparation. The study procedures will occur during scheduled surgery and will not alter the anesthetic or surgical management of participants.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
55

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Oct 2023

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 3, 2023

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 28, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 28, 2024

Completed
2.4 years until next milestone

First Submitted

Initial submission to the registry

August 6, 2026

Completed
6 days until next milestone

First Posted

Study publicly available on registry

August 12, 2026

Completed
Last Updated

August 12, 2026

Status Verified

August 1, 2026

Enrollment Period

5 months

First QC Date

August 6, 2026

Last Update Submit

August 6, 2026

Conditions

Keywords

Gentle skin abrasionSkin preparationEMG monitoring3M Red Dot Trace Prep

Outcome Measures

Primary Outcomes (1)

  • EMG Response Amplitude Before Neuromuscular Blocking Drug Administration

    Amplitude of recorded EMG responses to train-of-four stimulation will be compared between routine electrode application and electrodes placed after gentle skin abrasion.

    During surgery, before paralytic drug administration

Secondary Outcomes (2)

  • Supramaximal Stimulus Current

    During device startup after anesthesia induction

  • EMG Response Amplitude After Neuromuscular Blocking Drug Administration

    During surgery, after paralytic drug administration

Study Arms (1)

Gentle Skin Abrasion and Standard Electrode Application

EXPERIMENTAL

Participants will receive standard TwitchView EMG-based neuromuscular blockade monitoring with routine electrode application on one wrist and EMG-based monitoring after gentle skin abrasion on the opposite wrist. EMG signal amplitudes and supramaximal stimulus currents will be compared between the routine and skin-prepped electrode sites within each participant.

Procedure: Gentle Skin Abrasion Before EMG-Based Neuromuscular Blockade Monitoring

Interventions

Gentle skin abrasion will be performed at the stimulus and recording electrode sites on one wrist using 3M Red Dot Trace Prep abrasive strips before applying standard TwitchView electrodes. The opposite wrist will receive routine electrode application without skin preparation. Two TwitchView monitors will be used to compare EMG signal amplitudes and supramaximal stimulus currents.

Also known as: Skin Preparation With 3M Red Dot Trace Prep
Gentle Skin Abrasion and Standard Electrode Application

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adult surgical patient aged 18 years or older
  • Classified as American Society of Anesthesiologists Physical Status I, II, or III
  • Scheduled to undergo an elective procedure in which use of a neuromuscular blocking drug is anticipated
  • Neuromuscular blockade monitoring would be standard care for the planned procedure
  • Procedure allows access to both wrists
  • Capable of signing informed consent

You may not qualify if:

  • Emergency procedure
  • Procedure in which neuromuscular blocking drugs are not anticipated
  • Access to at least one wrist and ankle is not possible
  • Unable to provide informed consent
  • Prior stroke
  • Hemiparesis or hemiplegia
  • Any other known neuromuscular disorder
  • Employee or student of the researcher
  • Pregnant women, fetuses, neonates, prisoners, children, or adults unable to consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Minnesota East Bank Medical Center

Minneapolis, Minnesota, 55414, United States

Location

Study Officials

  • Michael M Todd, MD

    University of Minnesota

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Masking Details
This is an open-label study. Study staff and clinical providers are aware of which electrode site receives routine application and which site receives gentle skin abrasion.
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Model Details: All participants will receive standard EMG-based neuromuscular blockade monitoring on one wrist and EMG-based neuromuscular blockade monitoring after gentle skin abrasion on the opposite wrist. EMG signal amplitudes and supramaximal stimulus currents will be compared within participants.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 6, 2026

First Posted

August 12, 2026

Study Start

October 3, 2023

Primary Completion

February 28, 2024

Study Completion

February 28, 2024

Last Updated

August 12, 2026

Record last verified: 2026-08

Locations